Institutional Ownership
Adagene Inc
CUSIP 005329107ADSADAGQ1 2026
13D / 13G Filings
28
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
22.8%
Max % of class reported
Institutional Holders
25
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
28 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | General Atlantic Singapore Fund Pte. Ltd. | 13G/A | — | — | SEC |
| 2 | Jan 29, 2026 | Smith Vincent C | 13G/A | 8.7% | 5.10M | SEC |
| 3 | Nov 14, 2025 | Wuxi Pharmatech Healthcare Fund I L.P. | 13G/A | 7.0% | 4.12M | SEC |
| 4 | Nov 14, 2025 | Panacea Venture Healthcare Fund II, L.P. | 13G/A | 3.8% | 2.25M | SEC |
| 5 | Jul 2, 2025 | Fmr LLC | 13G/A | 0.9% | 473.9K | SEC |
| 6 | May 15, 2025 | Wuxi Pharmatech Healthcare Fund I L.P. | 13G/A | 8.5% | 4.98M | SEC |
| 7 | May 12, 2025 | Fil Limited | 13G/A | 1.8% | 936.8K | SEC |
| 8 | Feb 19, 2025 | Peter Luo | 13D/A | 15.6% | — | SEC |
| 9 | Feb 14, 2025 | Panacea Venture Healthcare Fund II, L.P. | 13G/A | 5.5% | 3.04M | SEC |
| 10 | Feb 12, 2025 | Fil Limited | 13G/A | 7.8% | 4.09M | SEC |
18 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Adagene Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Exome Asset Management LLC | 736.8K | $2.89M |
| 2 | Ameriprise Financial Inc | 607.9K | $2.38M |
| 3 | Hsg Holding Ltd | 1.34M | $2.03M |
| 4 | Mill Creek Capital Advisors, LLC | 199.6K | $782.5K |
| 5 | Morgan Stanley | 66.1K | $259.3K |
| 6 | Invesco Ltd. | 47.1K | $184.7K |
| 7 | Smartharvest Portfolios, LLC | 40.3K | $158.0K |
| 8 | Kamunting Street Capital Management, L.P. | 38.1K | $149.0K |
| 9 | Persistent Asset Partners Ltd | 35.1K | $137.7K |
| 10 | Dauntless Investment Group, LLC | 34.8K | $136.3K |